### The STEP 5 Study: Long-Term Adherence The STEP 5 two-year extension study (*Nature Medicine*, 2022) showed: - Patients who maintained consistent dosing for 2 years sustained an average weight loss of 15.2% - Adherence was the strongest predictor of long-term success - Patients who missed occasional doses (but did not discontinue) still achieved meaningful results - The difference between "perfect" adherence and "good" adherence (missing 12 doses per quarter) was relatively small **Key takeaway**: Don't panic about occasional missed doses
June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
This level of customization ensures that treatment fits seamlessly into each patients lifestyle and health requirements
Taking either cut risk by a quarter in a study of 4,740 elderly residents of Cache County, Utah .[ii] A study of all studies to date show, that either a high vitamin E or C intake showed a trend of attenuating risk by about 26 per cent according to Chinas leading prevention expert Professor Jin Tai Yu of Fudan University in Shanghai, making these nutrients grade 1 top level prevention factors.[iii] Vitamin C, which is water based and protects you against smoke and pollution, and vitamin E, which is fatThere are many different types of fats